One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-148948
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 45 |
Affiliation: Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Northwestern University, University of Nebraska Medical Center, The University of Texas MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, University of Colorado Denver, Fred Hutch Cancer Center, University of California, San Francisco, UPMC Hillman Cancer Center, Northside Hospital, Levine Cancer Institute, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Italy), City Of Hope National Medical Center
Two-Year Follow-up of Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphomas (LBCL)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
